These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 25914930)
1. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer. Intven M; Monninkhof EM; Reerink O; Philippens ME Acta Oncol; 2015 Nov; 54(10):1729-36. PubMed ID: 25914930 [TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330 [TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study. Jacobs L; Intven M; van Lelyveld N; Philippens M; Burbach M; Seldenrijk K; Los M; Reerink O Ann Surg; 2016 Mar; 263(3):522-8. PubMed ID: 26106836 [TBL] [Abstract][Full Text] [Related]
4. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy. Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759 [TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation. Intven M; Reerink O; Philippens ME J Magn Reson Imaging; 2015 Jun; 41(6):1646-53. PubMed ID: 25124320 [TBL] [Abstract][Full Text] [Related]
6. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study. Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270 [TBL] [Abstract][Full Text] [Related]
7. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters. Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867 [TBL] [Abstract][Full Text] [Related]
8. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI. Zou HH; Yu J; Wei Y; Wu JF; Xu Q J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601 [TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study. Genovesi D; Filippone A; Ausili Cèfaro G; Trignani M; Vinciguerra A; Augurio A; Di Tommaso M; Borzillo V; Sabatino F; Innocenti P; Liberatore E; Colecchia G; Tartaro A; Cotroneo AR Eur J Surg Oncol; 2013 Oct; 39(10):1071-8. PubMed ID: 23953231 [TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. De Felice F; Magnante AL; Musio D; Ciolina M; De Cecco CN; Rengo M; Laghi A; Tombolini V Eur J Surg Oncol; 2017 Jul; 43(7):1324-1329. PubMed ID: 28363512 [TBL] [Abstract][Full Text] [Related]
11. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI. Shi L; Zhang Y; Nie K; Sun X; Niu T; Yue N; Kwong T; Chang P; Chow D; Chen JH; Su MY Magn Reson Imaging; 2019 Sep; 61():33-40. PubMed ID: 31059768 [TBL] [Abstract][Full Text] [Related]
13. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Ippolito D; Monguzzi L; Guerra L; Deponti E; Gardani G; Messa C; Sironi S Abdom Imaging; 2012 Dec; 37(6):1032-40. PubMed ID: 22270580 [TBL] [Abstract][Full Text] [Related]
14. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy. Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248 [TBL] [Abstract][Full Text] [Related]
15. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters. Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761 [TBL] [Abstract][Full Text] [Related]
16. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging. Curvo-Semedo L; Lambregts DM; Maas M; Thywissen T; Mehsen RT; Lammering G; Beets GL; Caseiro-Alves F; Beets-Tan RG Radiology; 2011 Sep; 260(3):734-43. PubMed ID: 21673229 [TBL] [Abstract][Full Text] [Related]
17. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report. Petrillo M; Fusco R; Catalano O; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A Biomed Res Int; 2015; 2015():514740. PubMed ID: 26413528 [TBL] [Abstract][Full Text] [Related]
18. DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer. Heethuis SE; Goense L; van Rossum PSN; Borggreve AS; Mook S; Voncken FEM; Bartels-Rutten A; Aleman BMP; van Hillegersberg R; Ruurda JP; Meijer GJ; Lagendijk JJW; van Lier ALHMW Acta Oncol; 2018 Sep; 57(9):1201-1208. PubMed ID: 29781342 [TBL] [Abstract][Full Text] [Related]
19. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile. Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958 [TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient measurement covering complete tumor area better predicts rectal cancer response to neoadjuvant chemoradiotherapy. Blažić I; Maksimović R; Gajić M; Šaranović Đ Croat Med J; 2015 Oct; 56(5):460-9. PubMed ID: 26526883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]